Heart failure case disease management program: a pilot study of home telemonitoring versus usual care

被引:52
作者
Capomolla, S [1 ]
Pinna, G [1 ]
La Rovere, MT [1 ]
Maestri, R [1 ]
Ceresa, M [1 ]
Ferrari, M [1 ]
Febo, O [1 ]
Caporotondi, A [1 ]
Guazzotti, G [1 ]
Lenta, F [1 ]
Baldin, S [1 ]
Mortara, A [1 ]
Cobelli, F [1 ]
机构
[1] Inst Sci Montescano, Fdn Salvatore Maugeri, IRCCS, Dipartmento Cardiol, I-27040 Pavia, Italy
关键词
chronic heart failure; tetemonitoring; usual care;
D O I
10.1016/j.ehjsup.2004.09.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Telemonitoring care can be integrated into health care provision as a substitute for routine clinical follow-up. A telemonitoring service (TMS) integrated into the process of chronic heart failure (CHF) care has not so far been evaluated. Objectives We describe our comprehensive home TMS and evaluate its outcomes in comparison to the usual program of care after discharge from a Heart Failure Unit (HFU). Methods 133 patients discharged from a HFU, underwent risk cluster classification for cardiac events and were prospectively randomized to usual community care (n = 66) and to a management program delivered by the TMS (n = 67). Clinical outcome including re-hospitalization, cardiac death, and emergency room access, was compared in the two groups. Results Patients were clustered as at tow (n = 51), moderate (n = 43) and high (n = 39) risk. The compliance to telemonitoring was 82%. The compliance to system follow-up was (81%). The mean individual access rate to the TMS was 4.6 +/- 3.3 calls. Active interventions were made following 54% of the accesses. After 10 6 months, 135 events had occurred: 103 in the usual care group and 32 in telemonitoring group (P < 0.001). Re-hospitalisation was 22 (TMS) vs 77 (usual care) (P < 0.009). Cluster risk classification intercepted patients' increased health care demands (tow risk: 0.34 +/- 0.62; moderate risk 1 +/- 1.2; high risk 1.9 +/- 1.5 events). Conclusion A management program delivered by a TMS can reduce health care demands by CHF patients. (C) 2004 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:F91 / F98
页数:8
相关论文
共 35 条
[1]   Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure - The OSCUR study [J].
Bellotti, R ;
Badano, LP ;
Acquarone, N ;
Griffo, R ;
Lo Pinto, G ;
Maggioni, AP ;
Mattiauda, C ;
Menardo, G ;
Mombelloni, P .
EUROPEAN HEART JOURNAL, 2001, 22 (07) :596-604
[2]   Outcomes of chronic heart failure [J].
Benatar, D ;
Bondmass, M ;
Ghitelman, J ;
Avitall, B .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) :347-352
[3]   Cost/utility ratio in chronic heart failure: Comparison between heart failure management program delivered by day-hospital and usual care [J].
Capomolla, S ;
Febo, O ;
Ceresa, M ;
Caporotondi, A ;
Guazzotti, G ;
La Rovere, MT ;
Ferrari, M ;
Lenta, F ;
Baldin, S ;
Vaccarini, C ;
Gnemmi, M ;
Pinna, G ;
Maestri, R ;
Abelli, P ;
Verdirosi, S ;
Cobelli, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) :1259-1266
[4]  
CAPOMOLLA S, 2001, ITAL HEART J S, V2, pS45
[5]   External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases [J].
Casalino, L ;
Gillies, RR ;
Shortell, SM ;
Schmittdiel, JA ;
Bodenheimer, T ;
Robinson, JC ;
Rundall, T ;
Oswald, N ;
Schauffler, H ;
Wang, MC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :434-441
[6]   Clinical decision support systems to improve clinical practice and quality of care [J].
Classen, DC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15) :1360-1361
[7]   Clinical trials update from the European-Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II [J].
Coletta, AP ;
Louis, AA ;
Clark, AL ;
Nikitin, N ;
Cleland, JGF .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (05) :661-666
[8]   Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure [J].
Coletta, AR ;
Nikitin, N ;
Clark, AL ;
Cleland, JGE .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (01) :95-99
[9]   Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure [J].
Fonarow, GC ;
Stevenson, LW ;
Walden, JA ;
Livingston, NA ;
Steimle, AE ;
Hamilton, MA ;
Moriguchi, J ;
Tillisch, JH ;
Woo, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (03) :725-732
[10]   β-blocker therapy in heart failure -: Scientific review [J].
Foody, JM ;
Farrell, MH ;
Krumholz, HM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07) :883-889